Investigating Patterns in Enrollment and Engagement Among Individuals Coping With Anxiety Disorder
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Anxiety Disorder
- Sponsor
- Power Life Sciences Inc.
- Enrollment
- 500
- Locations
- 1
- Primary Endpoint
- Rate of anxiety disorder patients who remain in clinical trial to trial completion
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
Clinical trials, specifically focused on anxiety disorder, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.
The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Aged ≥ 18 years old
- •Diagnosis of anxiety disorder
- •Able to comprehend the investigational nature of the protocol and provide informed consent
Exclusion Criteria
- •Female patients who are currently pregnant or nursing
- •Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
- •Inability to perform regular electronic reporting
Outcomes
Primary Outcomes
Rate of anxiety disorder patients who remain in clinical trial to trial completion
Time Frame: 12 months
Number of anxiety disorder patients who decide to enroll in a clinical research
Time Frame: 3 months